ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

COCP Cocrystal Pharma Inc

1.48
0.00 (0.00%)
Pre Market
Last Updated: 07:00:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Cocrystal Pharma Inc COCP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 1.48 07:00:00
Open Price Low Price High Price Close Price Prev Close
1.48
more quote information »

Recent News

Date Time Source Heading
3/18/20248:51IHNWFeaturedElevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
3/18/20248:09IHNWFeaturedProspera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation
3/01/202416:15EDGAR2Form 8-K - Current report
1/08/202408:00EDGAR2Form 8-K - Current report
1/04/202416:01EDGAR2Form 8-K - Current report
1/04/202408:00GLOBECocrystal Pharma Provides an Update on the Clinical..
1/02/202409:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/21/202317:00EDGAR2Form 8-K - Current report
12/06/202308:00EDGAR2Form 8-K - Current report
12/06/202308:00GLOBECocrystal Pharma Announces First-Patient-In for Phase 2a..
12/04/202308:00EDGAR2Form 8-K - Current report
11/29/202308:00EDGAR2Form 8-K - Current report
11/29/202308:00GLOBECocrystal Pharma Highlights its Novel Inhaled and Oral..
11/27/202308:00GLOBECocrystal Pharma to Present at the NobleCon 19 Conference on..
11/13/202308:15EDGAR2Form 8-K - Current report
11/13/202308:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202308:00GLOBECocrystal Pharma Reports Third Quarter 2023 Financial..
11/09/202308:00GLOBECocrystal Pharma to Discuss Progress with Novel Inhaled and..
10/31/202308:00EDGAR2Form 8-K - Current report
10/31/202308:00GLOBECocrystal Pharma Receives UK MHRA Authorization to Initiate..
9/28/202308:00GLOBECocrystal Pharma Doses First Subjects in Clinical Study of..
9/05/202308:00GLOBECocrystal Pharma to Participate in the H.C. Wainwright..
8/16/202316:05EDGAR2Form 8-K - Current report
8/14/202308:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202308:00GLOBECocrystal Pharma Reports Second Quarter 2023 Financial..
8/08/202308:00GLOBECocrystal Pharma Selects Novel Oral Protease Inhibitor..
7/20/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/20/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/20/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/20/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/31/202308:00GLOBECocrystal Pharma Receives HREC Approval to Initiate Phase 1..
5/15/202308:00GLOBECocrystal Pharma Reports First Quarter 2023 Financial..
5/04/202316:05GLOBECocrystal Pharma Presents New Data from its CC-42344 Phase 1..
4/24/202308:00GLOBECocrystal Pharma Appoints Pharma Industry Veteran Fred..
4/18/202308:00GLOBECocrystal Pharma to Present New Data from its CC-42344 Phase..
4/10/202308:30GLOBECocrystal Pharma Completes $4 Million Private Placement..
3/29/202308:00GLOBECocrystal Pharma Reports 2022 Financial Results and Provides..
3/22/202308:00GLOBECocrystal Pharma to Highlights Progress with Its Antiviral..

Your Recent History

Delayed Upgrade Clock